Contact Information
Company Information
Company
Delix Therapeutics
Annual Revenue
10000000.0
Professional Summary
Mark Rus serves as Chief Executive Officer & Director at Delix Therapeutics. Delix Therapeutics operates in the research sector with approximately 31.0 employees. The company is headquartered in Boston, Massachusetts. Delix Therapeutics generates annual revenue of 10000000.0. To date, Delix Therapeutics has raised 80825000.0 in total funding, with the most recent round being Other.
Industry & Role Insights
-
•
MessageCEO tracks 2,961 executives in the research sector.
-
•
3,781 executive contacts are available in Massachusetts.
-
•
Our database includes 201,469 c suite-level executives.
Technologies
Outlook
Microsoft Office 365
Amazon AWS
Mobile Friendly
Vimeo
Apache
Render
Remote
Keywords
biotechnology research
brain health
neuroplasticity
neuroplastogens
mental health
neurological treatments
non-hallucinogenic compounds
psychedelic research
neurological conditions
therapeutic options
circuit-selective
functional neuroplasticity
structural neuroplasticity
oral medications
patient care
neuropsychopharmacology
neurodevelopmental disorders
neuropsychiatric conditions
novel therapeutics
pharmacology
clinical trials
psychedelic analogs
innovative solutions
safe medication
fast-acting treatments
sustained therapy
neuroscience innovation
patient access
scalable solutions
brain disorders
mental function improvement
neuroplastic medicines
research publications
biomedical research
therapeutics development
drug discovery
psychoplastogens
psychedelic pioneer
neuroscience team
fda regulations
evidence-based medicine
healthcare solutions
emerging therapies
patient population
unmet medical needs
neurochemical pathways
bioavailability
therapeutic efficacy
technological advancements
hospital & health care
health care
health
wellness & fitness
Related Executives
Outreach Guidance — research Sector
Executives like Mark Rus in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Delix Therapeutics.
Mark Rus's Position in the MessageCEO Database
- •Mark Rus is 1 of 1 verified executive contact we track at Delix Therapeutics.
- •2,871 verified executive contacts in research are in the MessageCEO database.
- •3,577 verified executive contacts in Massachusetts are in the database.
- •46 verified contacts work at research companies in the 31.0 employee range (same size as Delix Therapeutics).
Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated July 2026.
Frequently Asked Questions
How do I reach Mark Rus directly?
Mark Rus's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Executive Officer & Director at Delix Therapeutics. Access direct contact info to skip gatekeepers and reach the decision maker.
What company does Mark Rus work for?
Mark Rus is Chief Executive Officer & Director at Delix Therapeutics, a company in the research sector with 31.0 employees. The company is based in Boston, Massachusetts.
Can I pitch or sell to Mark Rus?
As Chief Executive Officer & Director at Delix Therapeutics, Mark Rus is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach Mark Rus directly — ideal for B2B sales, partnerships, and executive recruiting.
What industry is Mark Rus in?
Mark Rus works in the research industry as Chief Executive Officer & Director at Delix Therapeutics. MessageCEO provides verified contact information for executives across all major industries.
Is Mark Rus's contact information verified?
Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Mark Rus's profile is kept up-to-date with the latest available information.
Last updated: July 23, 2026
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans